SAB Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SABS and other ETFs, options, and stocks.About SABS
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
SABS Key Statistics
Stock Snapshot
SAB Biotherapeutics(SABS) stock is priced at $3.85, giving the company a market capitalization of 183.29M. It carries a P/E multiple of -1.29.
On 2026-02-06, SAB Biotherapeutics(SABS) stock traded between a low of $3.81 and a high of $4.00. Shares are currently priced at $3.85, which is +1.0% above the low and -3.7% below the high.
SAB Biotherapeutics(SABS) shares are trading with a volume of 26.26K, against a daily average of 426.95K.
In the last year, SAB Biotherapeutics(SABS) shares hit a 52-week high of $6.60 and a 52-week low of $1.00.
In the last year, SAB Biotherapeutics(SABS) shares hit a 52-week high of $6.60 and a 52-week low of $1.00.
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.